Latest Commercial Contracts News

Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.

QPM Energy Limited has announced a substantial upgrade to its Moranbah Gas Project reserves and resources, now certified at over 1,000 petajoules, positioning the company as a key player in Queensland’s evolving gas and electricity markets.

Memphasys Limited has advanced its Felix™ System commercial rollout with key regulatory approvals and new international contracts, while trimming operating costs and narrowing losses in the first half of FY2026.

Latrobe Magnesium has successfully achieved continuous production of magnesium oxide from brown coal ash at its Hazelwood North Demonstration Plant, marking a critical step towards magnesium metal production later this year.

HyTerra Limited has partnered with Prometheus Hydrogen to demonstrate an integrated geologic hydrogen production and delivery system in the US, aiming to complete by December 2026. This collaboration could pave the way for commercial-scale hydrogen supply to government and defense sectors.

Fortifai Limited has launched a detailed roadmap for Nol8’s Agentic AI Data Plane technology, promising a dramatic leap in AI data processing speed and efficiency ahead of a commercial platform launch by the end of 2026.

Australian Clinical Labs reported a modest revenue dip but achieved growth in earnings and margins in 1H26, while updating FY26 guidance and addressing wage increases mandated by the Fair Work Commission.

Austal Limited has revised its FY2026 EBIT guidance downward by approximately A$25 million following the discovery of an overstatement in incentives related to its T-ATS program by its US subsidiary.

Blue Star Helium has activated its CO2 removal unit at the Pinon Canyon Plant, marking a key milestone in its Galactica Project and paving the way for integrated operations and sales growth in 2026.

Vitrafy Life Sciences has delivered key milestones in the first half of FY26, including a strategic partnership with IMV Technologies and progress in clinical studies, while maintaining a strong cash position to support its U.S. expansion and product launches.

5E Advanced Materials has successfully closed an oversubscribed US$36 million public offering, positioning itself to advance its boron operations and finalise key commercial contracts.

5E Advanced Materials is raising up to $36 million through a stock offering to fund the development of its Fort Cady boron and lithium project in California. The capital raise comes amid ongoing concerns about the company’s ability to continue as a going concern without further financing.